Photoenzymatic Hydroalkylation Enables Streamlined Access to Aryl Glutarimide Precursors

Z Zhi Xu (State Key Laboratory of Chemical Engineering, School of Chemical Engineering, East China University of Science and Technology, No.130 Meilong Road, Shanghai, 200237, P. R. China) P Prasun Mukherjee (Department of Chemistry) S Steven Gossert (Integrated Materials Engineering & Technology Bristol Myers Squibb New Brunswick New Jersey USA) S Stephen Thomas (Microbiology and Immunology, State University of New York Upstate Medical University) V Vasil H. Vasilev (Department of Chemistry, University of California─Berkeley, 826 Latimer Hall, Berkeley, California 94720, United States) E Eric R. Welin (Global Discovery Chemistry, Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States) Y Yichen Tan (Chemical Process Development Bristol Myers Squibb New Brunswick New Jersey USA) S Shane M. McKenna (Chemical Process Development Bristol Myers Squibb Company Wirral UK) M Megan A. Emmanuel (Chemical Process Development Bristol Myers Squibb New Brunswick New Jersey USA) T Todd K. Hyster (Department of Chemistry)

Abstract

ABSTRACT We describe a photoenzymatic hydroalkylation reaction that enables the efficient and stereocontrolled synthesis of aryl glutarimide precursors—chemically and configurationally robust entry points to bioactive agents for targeted protein degradation. Screening of flavin‐dependent “ene”‐reductases identified GluER HA rac , a G. oxydans variant, as an efficient and substrate‐tolerant catalyst, granting access to >30 (hetero)aryl glutarimide precursors. A directed evolution campaign then furnished a hexamutant, GluER HA ent , that delivers the products in up to 93:7 enantiomeric ratio. Mechanistic experiments revealed a pathway that departs from the hydrogen atom transfer mechanism previously established for related systems, proceeding instead via radical–polar crossover followed by enantioselective proton transfer from an active‐site tyrosine residue. Collectively, these studies establish a biocatalytic platform for advancing the synthesis and diversification of glutarimide‐containing degraders.

Article Details

Volume / Issue Vol. 65, Issue 18
Published April 27, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (10)

Z

Zhi Xu

State Key Laboratory of Chemical Engineering, School of Chemical Engineering, East China University of Science and Technology, No.130 Meilong Road, Shanghai, 200237, P. R. China

P

Prasun Mukherjee

Department of Chemistry

S

Steven Gossert

Integrated Materials Engineering & Technology Bristol Myers Squibb New Brunswick New Jersey USA

S

Stephen Thomas

Microbiology and Immunology, State University of New York Upstate Medical University

V

Vasil H. Vasilev

Department of Chemistry, University of California─Berkeley, 826 Latimer Hall, Berkeley, California 94720, United States

E

Eric R. Welin

Global Discovery Chemistry, Bristol Myers Squibb, 10300 Campus Point Drive, Suite 100, San Diego, California 92121, United States

Y

Yichen Tan

Chemical Process Development Bristol Myers Squibb New Brunswick New Jersey USA

S

Shane M. McKenna

Chemical Process Development Bristol Myers Squibb Company Wirral UK

M

Megan A. Emmanuel

Chemical Process Development Bristol Myers Squibb New Brunswick New Jersey USA

T

Todd K. Hyster

Department of Chemistry